LifeSci Partnering & Analytics Announces Business Combination with Corsica Life Sciences and Launch of LifeSci Consulting - read this article along with other careers information, tips and advice on BioSpace
/PRNewswire/ Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases,.
62% vs. 25% overall response rates with navicixizumab plus paclitaxel in biomarker positive vs. biomarker negative patients using the Xerna™ TME Panel .
Quanta to Present at the LifeSci Partners Private Company globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.